Key facts
- Mark Coleman, director at Axsome Therapeutics, sold $4.02 million in stock.
- Pickett, director at Copt Defense Properties, sold $1.03 million in stock.
- Jack Cogen, director at CoreWeave, sold $29 million in CRWV shares.
- Andrea Redmond, director at Allstate, sold 10,000 shares valued at $451,474 on March 8.
- Joseph Gebbia, director at Airbnb, sold $35.9 million of ABNB stock.
- Jeri Williams, director at Axon Enterprise, sold $295,000 in company stock.
- Saira Ramasastry, director at Mirum, sold $397,700 of stock.
- Karen Holcom, CFO at Acuity, sold $629,318 in company stock.
- Andrew Briggs, director at Farmers & Merchants Bancorp, sold 2,451 shares valued at $248,010.
- Mark Reddout, president at Innovex International, sold $301,000 in stock.
- Morris Young, CEO at Axt, sold $22.3 million in company stock.
- Amitabh Misra, CTO at Sprinklr, sold $267,151 in CXM stock.
Multiple corporate executives and directors have recently divested substantial portions of their holdings in their respective companies. Among the notable transactions, Axsome Therapeutics director Mark Coleman sold $4.02 million worth of company stock. Similarly, Airbnb director Joseph Gebbia offloaded $35.9 million of ABNB stock, as reported in regulatory filings. CoreWeave director Jack Cogen also conducted a significant sale, disposing of $29 million in CRWV shares.
Further insider selling activity includes Allstate director Andrea Redmond, who sold 10,000 shares valued at $451,474 on March 8. Copt Defense Properties director Pickett sold $1.03 million in company stock. Axon Enterprise director Jeri Williams sold stock valued at $295,000, while Mirum director Saira Ramasastry sold $397,700 of stock. Acuity CFO Karen Holcom's sale amounted to $629,318.
Farmers & Merchants Bancorp director Andrew Briggs sold 2,451 shares for $248,010. Innovex International president Mark Reddout sold $301,000 worth of stock. Axt CEO Morris Young's divestment reached $22.3 million. Sprinklr Chief Technology Officer Amitabh Misra sold $267,151 in CXM stock. Spyre Therapeutics Chief Medical Officer Sheldon Sloan sold $624,975 of stock. Xeris Biopharma director John Johnson sold 91,422 shares valued at $91,422. Lastly, Insulet Corp director Luciana Borio sold 1,350 shares valued at $59,886.
These transactions represent insider sales, a common occurrence that investors often monitor for potential signals about a company's future performance or valuation. The individuals involved hold positions such as director, CEO, CFO, president, or CTO within their respective organizations.